Save time and get answers to complex questions with AI chat
What are the most memorable drug brands in oral factor b inhibitors? in united statesAlbendazole side effects in humans?Excipients list used in dexamethasone creams?Cost promethazine price?How long have hydroxyzine pamoate been on the market?
See the DrugPatentWatch profile for humira
US loss of exclusivity (LOE) for Humira (adalimumab) occurred on January 31, 2023. This marked the end of AbbVie’s U.S. patent protection and allowed biosimilars to begin entering the U.S. market in 2023. If you’d like, I can list which biosimilars launched and when, or explain the difference between patent expiry and regulatory exclusivity.
Other Questions About Humira :